Tibotec introduces new dosage strength for Prezista

The new dosage strength was approved by the FDA on February 25, 2008. The recommended oral dose of Prezista for treatment-experienced adult patients with HIV-1 is 600mg (one 600mg tablet or two 300mg tablets) taken twice daily with ritonavir 100mg, in combination with other antiretroviral agents, and with food.

Prezista, coadministered with 100mg ritonavir and with other antiretroviral agents, is currently indicated for the treatment of human immunodeficiency virus (HIV) infection in antiretroviral treatment-experienced adult patients, such as those with HIV-1 strains resistant to more than one protease inhibitor.